Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Haemonetics Corp (NY: HAE )

85.55 +0.12 (+0.14%)
Official Closing Price Updated: 7:00 PM EST, Nov 22, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Haemonetics Corp

< Previous 1 2 3 4 5 Next >
The Daily Biotech Pulse: Double Dose Of Positive Tidings For Merck, Alkermes Slips On Partial Termination Of J&J Licensing Deal, Amgen Migraine Drug Data
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Merck Gets Antitrust Nod For Acceleron Deal In Germany, Austria, Announces... 
Via Benzinga
Haemonetics' Vascade Vascular Closure Device Includes Same-Day Discharge Label
Haemonetics Corp's (NYSE: HAE) Vascade MVP Venous Vascular Closure System becomes the first vascular closure device to receive FDA indication for same-day discharge... 
Via Benzinga
Exposures Product Safety
The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight
Biopharma stocks ended higher for the week ending Aug. 6, as the sector latched on to the optimism that was evident in the broader markets. Earnings continued to flow in,... 
Via Benzinga
Exposures Product Safety
What 8 Analyst Ratings Have To Say About Haemonetics
Analysts have provided the following ratings for Haemonetics (NYSE: 
Via Benzinga
The Week Ahead In Biotech (Nov. 7-Nov. 13): Earnings Taper Off, Multiple Conference Presentations, IPOs And More
Biotech stocks reversed course and closed the week ended Nov. 5 lower, squandering the gains notched early in the week. What was good news for Pfizer, Inc. (NYSE: PFE) turned out... 
Via Benzinga
Looking into Haemonetics's Return on Capital Employed
After pulling data from Benzinga Pro it seems like during Q1, Haemonetics (NYSE:HAE) posted sales of $228.53 million. Earnings were up 61.57%, but Haemonetics still reported an... 
Via Benzinga
The Daily Biotech Pulse: Merck Rallies On Antiviral Pill Data, Gilead Files For Yescarta Label Expansion, Exscientia IPO
Here's a roundup of top developments in the biotech space over the last 24 hours. Click here for accessing Benzinga's FDA Calendar Scaling The Peaks (Biotech Stocks... 
Via Benzinga
Exposures Product Safety
Haemonetics Corp (HAE) Q1 2022 Earnings Call Transcript
HAE earnings call for the period ending July 3, 2021. 
Via The Motley Fool
Topics Earnings
Exposures Financial
The Daily Biotech Pulse: FDA Rejects FibroGen's Anemia Drug, Crinetics Gains On Positive Readout, BioCryst Withdraws Public Offering
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 10) Alnylam Pharmaceuticals,... 
Via Benzinga
Exposures Product Safety
Recap: Haemonetics Q1 Earnings
Shares of Haemonetics (NYSE:HAE) remained unaffected after the company reported Q1 results. Quarterly Results Earnings per share increased 8.70% year over year to $0.50,... 
Via Benzinga
Cramer Gives His Opinion On Virgin Galactic, Zynex And More
On CNBC's "Mad Money Lightning Round," Jim Cramer said Virgin Galactic Holdings Inc (NYSE: SPCE) is a very expensive stock. It had a nice run, but he would look for... 
Via Benzinga
Why Haemonetics Stock Rallied on Friday
One analyst upgrade in particular seemed to bring back the bulls. 
Via The Motley Fool
What Does Haemonetics Debt Look Like?
Shares of Haemonetics (NYSE:HAE) fell by 57.47% in the past three months. Before having a look at the importance of debt, let us look at how much debt Haemonetics has.... 
Via Benzinga
A Look Into Haemonetics Price Over Earnings
In the current market session, Haemonetics Inc. (NYSE:HAE) is trading at $56.67, after a 9.38% increase. However, over the past month, the stock fell by 51.55%, and... 
Via Benzinga
Where Haemonetics Stands With Analysts
Analysts have provided the following ratings for Haemonetics (NYSE:HAE) within the last quarter: Last 30 Days 1 Month Ago 2 Months Ago 3 Months Ago Bullish 1 2 0 0... 
Via Benzinga
The Daily Biotech Pulse: CorMedix Slumps On Delay In Resubmission of DefenCath NDA, Apellis Awaits FDA Decision, Vera Therapeutics Debuts
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 13) Alexion Pharmaceuticals, Inc... 
Via Benzinga
Exposures Product Safety
77 Biggest Movers From Yesterday
Gainers AMC Entertainment Holdings, Inc. (NYSE: AMC) shares surged 23.7% to close at $12.77. Moxian, Inc. (NASDAQ: MOXC) jumped 23.6% to close at $9.52. Repro Med Systems, Inc... 
Via Benzinga
Why Haemonetics Stock Fell 13% Today
Investors don't seem to be buying the company's rosy 2022 guidance. 
Via The Motley Fool
Haemonetics Corp (HAE) Q4 2021 Earnings Call Transcript
HAE earnings call for the period ending April 3, 2021. 
Via The Motley Fool
Topics Earnings
Exposures Financial
44 Stocks Moving In Thursday's Mid-Day Session
Gainers Reliance Global Group, Inc. (NASDAQ: RELI) jumped 38.7% to $4.0901 after the company said it has acquired a premier health insurance agency, J.P. Kush and Associates, Inc... 
Via Benzinga
Mid-Morning Market Update: Markets Open Higher; US Jobless Claims Decline To 473,000
Following the market opening Thursday, the Dow traded up 1.41% to 34,060.34 while the NASDAQ rose 1.36% to 13,209.44. The S&P also rose, gaining 1.32% to 4,116.69. The U.S.... 
Via Benzinga
Topics Stocks
Exposures US Equities
Stocks That Hit 52-Week Lows On Thursday
During Thursday's morning session, 24 stocks hit new 52-week lows. Facts of Interest: American Well (NYSE:AMWL) was the largest firm by market cap to set a new... 
Via Benzinga
The Daily Biotech Pulse: Merck Reports Positive Keytruda Data In Breast Cancer, Curis, Evoke Slump On Earnings, Qiagen's Rapid COVID-19 Antibody Test OK'ed For Emergency Use
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 12) Alexion Pharmaceuticals, Inc... 
Via Benzinga
Exposures COVID-19
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Gainers Palisade Bio (NASDAQ:PALI) shares moved upwards by 35.23% to $7.1 during Thursday's pre-market session. Lianluo Smart (NASDAQ:LLIT) shares rose 19.37% to $7.21... 
Via Benzinga
Recap: Haemonetics Q4 Earnings
Shares of Haemonetics (NYSE:HAE) rose 2.1% in pre-market trading after the company reported Q4 results. Quarterly Results Earnings per share were down 33.33% over the past... 
Via Benzinga
Stocks That Hit 52-Week Lows On Monday
Monday morning saw 78 companies set new 52-week lows. Intriguing Points: The largest company by market cap to set a new 52-week low was Rocket Companies (NYSE:RKT).... 
Via Benzinga
The Daily Biotech Pulse: Minerva, InflaRx Report Positive Data Readouts, Lucira COVID-19 Test Kit Available On Amazon, Decision Day For Heron
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 11) HOOKIPA Pharma Inc. (NASDAQ... 
Via Benzinga
Exposures COVID-19
The Week Ahead In Biotech (May 9-15): Heron, Apellis FDA Decisions, Presentations and Earnings
Biotech stocks came under pressure in the week ended May 7 as traders digested a slew of earnings news flow and a handful of clinical trial readouts. COVID-19 vaccine stocks came... 
Via Benzinga
Exposures COVID-19 Product Safety
The Daily Biotech Pulse: Split Verdict For Chemocentryx, NKarta-CRISPR In Cell Therapy Collaboration, Orphazyme's Clinical Trial Setback, 2 IPOs
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 6) GT Biopharma, Inc. (NASDAQ:... 
Via Benzinga
The Daily Biotech Pulse: Merck's Keytruda Snags Another FDA Approval, Moderna Slips On Revenue Miss, Chemocentryx Adcom
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 5) AbbVie Inc. (NYSE: ABBV)... 
Via Benzinga
Exposures Product Safety
< Previous 1 2 3 4 5 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.